Evidence map›Paper›PMID 28521548›Full record

ArticleMitochondrial DNA. Part A, DNA mapping, sequencing, and analysis2018

Mitochondrial DNA heteroplasmy in cardiac tissue from individuals with and without coronary artery disease.

Erik Hefti, Javier Guillermo Blanco

Abstract readComparative Study
In one paragraph

Article in Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review.Arteriosclerosis, thrombosis, and vascular biology · 2020
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Erik Heftia Department of Pharmaceutical Sciences, The School of Pharmacy and Pharmaceutical Sciences , The State University of New York at Buffalo , Buffalo , NY , USA.ORCID 0000-0003-0358-2539
Javier Guillermo Blancoa Department of Pharmaceutical Sciences, The School of Pharmacy and Pharmaceutical Sciences , The State University of New York at Buffalo , Buffalo , NY , USA.
University at Buffalo, State University of New York · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
PHARMACOGENETICS OF HUMAN CARBONYL REDUCTASESR01GM073646 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BLANCO, JAVIER GUILLERMO · 2005 to 2019
$4.1M
NCATS NIH HHS UL1 TR001412NIGMS NIH HHS R01 GM073646
6 · The paper itself

Abstract

The cellular environment associated with coronary artery disease (CAD) can lead to mitochondrial DNA (mtDNA) damage. Mitochondrial variants in some copies of mtDNA (heteroplasmy) and mtDNA content are potential genetic biomarkers for CAD-associated disease states. Massively parallel sequencing and qRT-PCR techniques were used to measure heteroplasmic variants and mtDNA content in heart samples from donors with (n = 8) and without (n = 7) documented CAD. Both groups showed increased numbers of heteroplasmic mtDNA variants in the control region (CR) (p < .0010, ANOVA). The donors with CAD displayed a 41.07% increase in heteroplasmic mtDNA variant number in the CR (p = .043), an 87.50% increase in the number of heteroplasmic mtDNA deletions (p = .12), and a 48.76% increase in the number of heteroplasmic mtDNA single nucleotide variants (p = .029). These data suggest potential trends towards higher cardiac mtDNA heteroplasmy levels in heart samples from donors with CAD.

Indexed as

Genetic VariationGenome, MitochondrialAdultAgedAged, 80 and overCase-Control StudiesCoronary Artery DiseaseDNA, MitochondrialFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMitochondria, HeartSequence Analysis, DNAYoung AdultDNA, MitochondrialCoronary artery diseaseheteroplasmymitochondriamitochondrial DNAmitochondrial variation

Identifiers

PMID28521548
PMCPMC5694712
OpenAlexW2615662934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.